Genistein Ameliorates Adverse Cardiac Effects Induced by Arsenic Trioxide Through Preventing Cardiomyocytes Apoptosis
Background/Aims: Arsenic trioxide (As2O3) is a highly effective agent for treatment of acute promyelocytic leukemia (APL). However, consecutively administered As2O3 induces serious adverse cardiac effects, including long QT syndrome (LQTs) and even sudden cardiac death. Previous studies have shown t...
Main Authors: | Yuhua Fan, Chen Wang, Yong Zhang, Pengzhou Hang, Yan Liu, Zhenwei Pan, Ning Wang, Zhimin Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2013-01-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/343351 |
Similar Items
-
Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01) -
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
by: Yu Zheng, et al.
Published: (2021-02-01) -
Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma
by: Ambroise Marçais, et al.
Published: (2020-03-01) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01) -
Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome
by: Yanan Jiang, et al.
Published: (2018-01-01)